Cushman & Wakefield reported third quarter 2026 revenue of $2.8 billion, up 8% from a year earlier, led by leasing and capital markets growth. Diluted EPS was flat at $0.22, while adjusted EPS rose 28% to $0.37, and the company kept its full-year 2026 adjusted EPS growth guidance of 18% to 23%.
Total revenue was $2,807.8 million, up 8% from $2,605.9 million; leasing revenue rose 15% and capital markets revenue rose 18%
Net income was $52.1 million, up 1%; diluted EPS was $0.22, flat with the prior year
Adjusted EPS was $0.37, up 28% from $0.29
Full-year 2026 adjusted EPS guidance of 18% to 23% growth was maintained
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Cushman & Wakefield plc's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$10.29B
+8.9%
$0.38
-32.1%
0.9%
FY2024
$9.45B
-0.5%
$0.56
—
1.4%
FY2023
$9.49B
-6.1%
$-0.16
-118.6%
-0.4%
FY2022
$10.11B
+7.6%
$0.86
-21.8%
1.9%
FY2021
$9.39B
+19.7%
$1.10
—
2.7%
Frequently asked questions
When is Cushman & Wakefield's next earnings date?
Cushman & Wakefield has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Cushman & Wakefield earn last quarter?
For the quarter ended Sep 2026, Cushman & Wakefield reported diluted EPS of $0.22 (+0.0% year over year) on revenue of $2.81B (+7.7%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.